These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 37801960)
1. Stem cells as a regenerative medicine approach in treatment of microvascular diabetic complications. Poojari AS; Wairkar S; Kulkarni YA Tissue Cell; 2023 Dec; 85():102225. PubMed ID: 37801960 [TBL] [Abstract][Full Text] [Related]
2. Addressing Stem Cell Therapeutic Approaches in Pathobiology of Diabetes and Its Complications. Peng BY; Dubey NK; Mishra VK; Tsai FC; Dubey R; Deng WP; Wei HJ J Diabetes Res; 2018; 2018():7806435. PubMed ID: 30046616 [TBL] [Abstract][Full Text] [Related]
3. Mesenchymal Stem Cell Exosomes as a New Strategy for the Treatment of Diabetes Complications. Xiong J; Hu H; Guo R; Wang H; Jiang H Front Endocrinol (Lausanne); 2021; 12():646233. PubMed ID: 33995278 [TBL] [Abstract][Full Text] [Related]
4. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T; Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481 [TBL] [Abstract][Full Text] [Related]
6. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus. Fullerton B; Jeitler K; Seitz M; Horvath K; Berghold A; Siebenhofer A Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD009122. PubMed ID: 24526393 [TBL] [Abstract][Full Text] [Related]
7. Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature. Nalysnyk L; Hernandez-Medina M; Krishnarajah G Diabetes Obes Metab; 2010 Apr; 12(4):288-98. PubMed ID: 20380649 [TBL] [Abstract][Full Text] [Related]
8. Treatment Goals in Diabetes. Melmer A; Laimer M Endocr Dev; 2016; 31():1-27. PubMed ID: 26824869 [TBL] [Abstract][Full Text] [Related]
9. [Continuing care of patients with cardiovascular risk in general practice: diabetic patients and their care]. Ilyés I; Jancsó Z; Kovács E; Márton H; Simay A Orv Hetil; 2005 Dec; 146(51):2581-8. PubMed ID: 16468612 [TBL] [Abstract][Full Text] [Related]
10. Why should we treat hyperglycaemia? Pelkonen R Ann Med; 1990 Jun; 22(3):207-9. PubMed ID: 2393556 [TBL] [Abstract][Full Text] [Related]
11. Bone Marrow-Derived Stem Cells: a Mixed Blessing in the Multifaceted World of Diabetic Complications. Mangialardi G; Madeddu P Curr Diab Rep; 2016 May; 16(5):43. PubMed ID: 27025211 [TBL] [Abstract][Full Text] [Related]
12. Potential Roles of Anti-Inflammatory Plant-Derived Bioactive Compounds Targeting Inflammation in Microvascular Complications of Diabetes. Kaabi YA Molecules; 2022 Oct; 27(21):. PubMed ID: 36364178 [TBL] [Abstract][Full Text] [Related]
14. The roles of mesenchymal stem cell-derived exosomes in diabetes mellitus and its related complications. Yang M; Chen J; Chen L Front Endocrinol (Lausanne); 2022; 13():1027686. PubMed ID: 36339446 [TBL] [Abstract][Full Text] [Related]
15. Urine-derived stem cell therapy for diabetes mellitus and its complications: progress and challenges. Zou Y; Li S; Chen W; Xu J Endocrine; 2024 Feb; 83(2):270-284. PubMed ID: 37801228 [TBL] [Abstract][Full Text] [Related]
16. A Review on Cellular and Molecular Mechanisms Linked to the Development of Diabetes Complications. Babel RA; Dandekar MP Curr Diabetes Rev; 2021; 17(4):457-473. PubMed ID: 33143626 [TBL] [Abstract][Full Text] [Related]
17. [The significance of compensation in diabetes mellitus in the development of diabetic microangiopathies (a review of the literature)]. Gendeleka GF Vrach Delo; 1989 Aug; (8):54-8. PubMed ID: 2686158 [No Abstract] [Full Text] [Related]
18. Prevention of the complications of diabetes. Vinik AI; Vinik E Am J Manag Care; 2003 Mar; 9(3 Suppl):S63-80; quiz S81-4. PubMed ID: 12653455 [TBL] [Abstract][Full Text] [Related]